Science Explorer Interactive view Map
Company · Kobe · Japan

Eli Lilly (Japan)

In research, Eli Lilly (Japan) stands highest in Medicine (#10,281 of 17,978 worldwide) and Health Sciences (#13,313 of 20,462 worldwide), over all time.

lilly.co.jpROR OpenAlex
World rank, all time
#30,985
of 42,892
Rank in Japan
#1,271
of 2,112
Research works
237
▲ 15% vs 2013–17
Citations
3.7k
15.7 per fractional work
Top-10% rate
18.6%
record average 16.5%
Open access
65%
world 28%

What is Eli Lilly (Japan) known for in research?

The fields where it stands highest, over all time, ranked among every institution above the floor in each field.

FieldWorld rankWhere that sitsTop-10% rateWorks
MedicineField #10,281 of 17,978 18.1%176
Health SciencesDomain #13,313 of 20,462 17.9%181

Each strip is that field’s whole ranked pool, with the notch where Eli Lilly (Japan) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 0.99× its world share, 3 worksBiochemistry, Geneti…Immunology and Microbiology: 2.69× its world share, 1 worksImmunology and Micro…Neuroscience: 1.56× its world share, 1 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 2.25× its world share, 0 worksPharmacology, Toxico…Chemistry: 0.02× its world share, 0 worksChemistryComputer Science: 0.03× its world share, 0 worksComputer ScienceMathematics: 0.22× its world share, 0 worksMathematicsHealth Professions: 0.78× its world share, 1 worksHealth ProfessionsMedicine: 4.26× its world share, 41 worksMedicineNursing: 0.19× its world share, 0 worksNursingEconomics, Econometrics and Finance: 0.92× its world share, 1 worksEconomics, Econometr…Psychology: 0.48× its world share, 1 worksPsychologySocial Sciences: 0.06× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Medicine, 4.3×. Every wedge is a field page.

Who are the top researchers at Eli Lilly (Japan)?

Ranked on the composite score, Sotaro Enatsu and Hiroyuki Uesaka lead among researchers whose main affiliation is Eli Lilly (Japan).

  1. 1 Sotaro Enatsu · #1,070,366 worldwide 15 citations · 19 works
  2. 2 Hiroyuki Uesaka · #1,557,868 worldwide 6 citations · 20 works
All ranked researchers at Eli Lilly (Japan)

Which keywords describe research at Eli Lilly (Japan)?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Glycemic Control, Insulin Therapy, Diabetes, Cardiovascular Disease, Type 2 Diabetes, Heart Failure, Obesity and Clinical Guidelines.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Glycemic Control8▲ 99×4 topics
  2. Insulin Therapy7▲ 119×3 topics
  3. Diabetes6▲ 22×5 topics
  4. Cardiovascular Disease5▲ 8.4×8 topics
  5. Type 2 Diabetes4▲ 36×3 topics
  6. Epidemiology4▲ 1.74×17 topics
  7. Heart Failure4▲ 16×3 topics
  8. Clinical Guidelines3▲ 23×3 topics
  9. Obesity3▲ 8.8×10 topics
  10. Cardiovascular Outcomes3▲ 115×1 topic
  11. Glucose Control3▲ 115×1 topic
  12. Chemotherapy3▲ 8.6×7 topics
  13. Inflammation3▲ 2.9×13 topics
  14. Type 1 Diabetes3▲ 70×2 topics
  15. Neurological Disorders3▲ 10×5 topics
  16. Quality of Life3▲ 3.8×10 topics
  17. Cardiovascular Risk3▲ 17×4 topics
  18. Complications2▲ 10×2 topics
  19. Continuous Glucose Monitoring2▲ 106×1 topic
  20. Hypoglycemia2▲ 106×1 topic
  21. Lifestyle Intervention2▲ 58×2 topics
  22. Metabolic Syndrome2▲ 6.1×7 topics
  23. Breast Cancer2▲ 20×5 topics
  24. Metastatic Breast Cancer2▲ 81×2 topics
  25. Clinical Trials2▲ 6.5×9 topics
  26. Calcitonin Gene-Related Peptide2▲ 100×2 topics
  27. Clinical Practice Guidelines2▲ 7.8×6 topics
  28. Critical Care2▲ 18×3 topics
  29. Headache Disorders2▲ 168×1 topic
  30. Migraine2▲ 99×1 topic
  31. Diabetes Mellitus2▲ 19×3 topics
  32. Encephalopathy2▲ 58×2 topics
  33. Atherosclerosis2▲ 13×4 topics
  34. Insulin Resistance2▲ 8.0×3 topics
  35. Cholesterol2▲ 24×2 topics
  36. Hyperglycemia2▲ 29×1 topic
  37. Infection Risk2▲ 92×1 topic
  38. Targeted Therapy2▲ 15×3 topics
  39. Global Prevalence2▲ 36×1 topic
  40. Glucose Metabolism2▲ 33×1 topic

Which research topics does Eli Lilly (Japan) publish most on?

By volume in 2022–2025: Diabetes Treatment and Management, Diabetes Management and Research, Migraine and Headache Studies and Hyperglycemia and glycemic control in critically ill and hospitalized patients.

Diabetes Treatment and Management: 3 fractional worksDiabetes Management and Research: 2 fractional worksMigraine and Headache St…2Migraine and Headache Studies: 2 fractional worksHyperglycemia and glycem…2Hyperglycemia and glycemic control in critically ill and hospitalized patients: 2 fractional worksDiabetes, Cardiovascular Risks, and Lipoproteins: 2 fractional worksAdvanced Breast Cancer Therapies: 2 fractional worksNeurological Complicatio…2Neurological Complications and Syndromes: 2 fractional worksRheumatoid Arthritis Research and Therapies: 1 fractional worksAlzheimer's disease research and treatments: 1 fractional worksDermatology and Skin Dis…1Dermatology and Skin Diseases: 1 fractional works
Endocrinology, Diabetes and MetabolismPsychiatry and Mental healthPulmonary and Respiratory MedicineRheumatology2 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Diabetes Treatment and Management Endocrinology, Diabetes and Metabolism 3 works
  2. 2 Diabetes Management and Research Endocrinology, Diabetes and Metabolism 2 works
  3. 3 Migraine and Headache Studies Psychiatry and Mental health 2 works
  4. 4 Hyperglycemia and glycemic control in critically ill and hospitalized patients Endocrinology, Diabetes and Metabolism 2 works
  5. 5 Diabetes, Cardiovascular Risks, and Lipoproteins Endocrinology, Diabetes and Metabolism 2 works
  6. 6 Advanced Breast Cancer Therapies Pulmonary and Respiratory Medicine 2 works
  7. 7 Neurological Complications and Syndromes Psychiatry and Mental health 2 works
  8. 8 Rheumatoid Arthritis Research and Therapies Rheumatology 1 works
  9. 9 Alzheimer's disease research and treatments Physiology 1 works
  10. 10 Dermatology and Skin Diseases Dermatology 1 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available64.9%not open35.1%

World: 28% of research is openly available.

with international co-authors40.7%domestic only59.3%

World: 19% is written across borders.

How has Eli Lilly (Japan)'s research output changed?

Output in 2018–2022 was 15% higher than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Kobe

All research institutions in Kobe

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.